AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimpure MV 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Arrient Healthcare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimpure MV 2mg/500mg/0.2mg Tablet

This anti-diabetic medication, Glimpure MV 2mg/500mg/0.2mg Tablet, is a combination therapy for adult patients with type 2 diabetes. It effectively manages blood glucose levels. Administer this tablet with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continuous use is crucial; discontinuation without medical consultation can elevate blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are key to diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and tremors. Recognize these symptoms and carry a quick-acting glucose source like juice or candy. Alcohol consumption increases hypoglycemia risk and should be limited. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Prior heart conditions should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is essential, along with potential blood tests to monitor blood cell counts and liver function.

Primary Ingredients of Glimpure MV 2mg/500mg/0.2mg Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Glimpure MV 2mg/500mg/0.2mg Tablet

Managing Type 2 diabetes

Major Benefits of Glimpure MV 2mg/500mg/0.2mg Tablet:

Your physician will determine the correct dosage and treatment length for this medication. Ingest the Glimpure MV 2mg/500mg/0.2mg Tablet whole; do not crush, chew, or divide it. Administer on an empty stomach.

Common Side effects of Glimpure MV 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimpure MV 2mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimpure MV 2mg/500mg/0.2mg tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

How Glimpure MV 2mg/500mg/0.2mg Tablet works:

Each Glimpure MV tablet (2mg/500mg/0.2mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimpure MV 2mg/500mg/0.2mg tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimpure MV 2mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glimpure MV 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

Employing Glimpure MV 2mg/500mg/0.2mg tablets in individuals with kidney disease carries a high risk and is best avoided. Patients should seek medical advice before use. This medication is contraindicated in those with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Glimpure MV 2mg/500mg/0.2mg tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a reduced dosage; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimpure MV 2mg/500mg/0.2mg Tablet :

Should you forget a Glimpure MV 2mg/500mg/0.2mg Tablet dose, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimpure MV 2mg/500mg/0.2mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Diabetes medication

FAQs on Glimpure MV 2mg/500mg/0.2mg Tablet

Glimpure MV 2mg/500mg/0.2mg tablets contain glimepiride, metformin, and voglibose. This medication treats type 2 diabetes mellitus by managing blood glucose levels in adults, complementing dietary changes and physical activity. Glimepiride stimulates insulin release from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and enhances insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal glucose levels. This combination is unsuitable for type 1 diabetes mellitus.
Taking Glimpure MV 2mg/500mg/0.2mg tablets may result in common adverse reactions including low blood glucose, queasiness, loose stools, taste disturbances, gas, abdominal discomfort, cephalalgia, dermatitis, and upper respiratory complaints.
Patients with hypersensitivity to Glimpure MV 2mg/500mg/0.2mg Tablet constituents or inactive ingredients should not use this medication. Its administration is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel conditions, colonic ulcers, and metabolic acidosis, encompassing diabetic ketoacidosis.
Consuming alcohol concurrently with Glimpure MV 2mg/500mg/0.2mg Tablets is inadvisable. This combination poses a risk of dangerously low blood glucose (hypoglycemia) and heightened lactic acidosis probability.
Indeed, Glimpure MV 2mg/500mg/0.2mg Tablets may induce hypoglycemia. Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of apprehension or tremors. This adverse effect is amplified by skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Retain this medication within its original, sealed packaging. Follow the storage guidelines printed on the package or label. Discard any leftover medication. Prevent access by children, pets, and others.
Glimpure MV 2mg/500mg/0.2...
165
MRP 201
17% off